ReviewEuropean heart journal. Cardiovascular pharmacotherapy2023

Biological basis and proposed mechanism of action of CSL112 (apolipoprotein A-I [human]) for prevention of major adverse cardiovascular events in patients with myocardial infarction.

Serge Korjian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.